Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian K Meyer

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
PDA Journal of Pharmaceutical Science and Technology|November 9, 2006
Impact of tubing material on the failure of product-specific bubble points of sterilizing-grade filtersBrian K Meyer, Diego Vargas
AAPS Pharmscitech|January 12, 2011
Comparison of compendial antimicrobial effectiveness tests: a reviewCheryl L Moser, Brian K Meyer
Journal of Pharmaceutical Sciences|August 28, 2007
Antimicrobial preservative use in parenteral products: past and presentBrian K Meyer, Alex Ni, Binghua Hu, et al.
Plos One|August 25, 2021
Frontiers in assessing septic systems vulnerability in coastal Georgia, USA: Modeling approach and management implicationsNahal Hoghooghi, J Scott Pippin, Brian K Meyer, et al.
Journal of Pharmaceutical Sciences|March 5, 2011
The use of flow cytometry for the detection of subvisible particles in therapeutic protein formulationsHenryk Mach, Akhilesh Bhambhani, Brian K Meyer, et al.
Vaccines|July 27, 2024
Development of a Cell-Based Reporter Potency Assay for Live Virus VaccinesDengyun Sun, Brian K Meyer, Dhanvanthri S Deevi, et al.
Journal of Pharmaceutical Sciences|March 24, 2010
An industry perspective on the monitoring of subvisible particles as a quality attribute for protein therapeuticsSatish K Singh, Nataliya Afonina, Michel Awwad, et al.
The Lancet. Infectious Diseases|April 11, 2016
Immune response and reactogenicity of intradermal administration versus subcutaneous administration of varicella-zoster virus vaccine: an exploratory, randomised, partly blinded trialChan R Beals, Radha A Railkar, Andrea K Schaeffer, et al.
Vaccine: X|August 7, 2019
Immune response and reactogenicity of an unadjuvanted intradermally delivered human papillomavirus vaccine using a first generation Nanopatch™ in rhesus macaques: An exploratory, pre-clinical feasibility assessmentBrian K Meyer, Mark A F Kendall, Donna M Williams, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
PDA Journal of Pharmaceutical Science and Technology|November 9, 2006
Impact of tubing material on the failure of product-specific bubble points of sterilizing-grade filtersBrian K Meyer, Diego Vargas
AAPS Pharmscitech|January 12, 2011
Comparison of compendial antimicrobial effectiveness tests: a reviewCheryl L Moser, Brian K Meyer
Journal of Pharmaceutical Sciences|August 28, 2007
Antimicrobial preservative use in parenteral products: past and presentBrian K Meyer, Alex Ni, Binghua Hu, et al.
Plos One|August 25, 2021
Frontiers in assessing septic systems vulnerability in coastal Georgia, USA: Modeling approach and management implicationsNahal Hoghooghi, J Scott Pippin, Brian K Meyer, et al.
Journal of Pharmaceutical Sciences|March 5, 2011
The use of flow cytometry for the detection of subvisible particles in therapeutic protein formulationsHenryk Mach, Akhilesh Bhambhani, Brian K Meyer, et al.
Vaccines|July 27, 2024
Development of a Cell-Based Reporter Potency Assay for Live Virus VaccinesDengyun Sun, Brian K Meyer, Dhanvanthri S Deevi, et al.
Journal of Pharmaceutical Sciences|March 24, 2010
An industry perspective on the monitoring of subvisible particles as a quality attribute for protein therapeuticsSatish K Singh, Nataliya Afonina, Michel Awwad, et al.
The Lancet. Infectious Diseases|April 11, 2016
Immune response and reactogenicity of intradermal administration versus subcutaneous administration of varicella-zoster virus vaccine: an exploratory, randomised, partly blinded trialChan R Beals, Radha A Railkar, Andrea K Schaeffer, et al.
Vaccine: X|August 7, 2019
Immune response and reactogenicity of an unadjuvanted intradermally delivered human papillomavirus vaccine using a first generation Nanopatch™ in rhesus macaques: An exploratory, pre-clinical feasibility assessmentBrian K Meyer, Mark A F Kendall, Donna M Williams, et al.
Pageof 1